Journal of International Society of Preventive and Community Dentistry

REVIEW ARTICLE
Year
: 2022  |  Volume : 12  |  Issue : 5  |  Page : 500--505

C3 targeted complement therapy for chronic periodontitis – A scoping review


Rupali Agnihotri1, Sumit Gaur2 
1 Department of Periodontology, Manipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, 576104, India
2 Department of Pedodontics and Preventive Dentistry, Manipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, 576104, India

Correspondence Address:
Dr. Sumit Gaur
Department of Pedodontics and Preventive Dentistry, Manipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education (MAHE), Manipal, Karnataka
India

Aim: Chronic Periodontitis (CP) is a complex disease initiated by inflammation caused by dysbiotic bacterial communities in the subgingival environment. The Porphyromonas gingivalis, a keystone pathogen at low colonization, causes immune subversion of complement component C5aR, leading to complement C3-dependent destructive inflammation responsible for the inflammatory bone loss in CP. Animal studies have shown that targeting complement C3 with its inhibitor like AMY-101 may help reduce inflammatory bone loss in CP. This scoping review elaborates on the role of complement C3 targeted therapy for CP. Materials and Methods: About 66 original studies were obtained during an initial electronic search in Medline (Pubmed), Scopus, Web of Science, and Embase. About four articles were included in the review after screening the duplicates and reading the full text. Their aims and objectives, drug dosage, route of administration, results, and conclusions were recorded. Results: Of the four-original research, 3 were animal studies and one randomized Phase IIa clinical trial. They showed that C3 targeted complement therapy reduced the inflammatory and clinical periodontal parameters in CP. Conclusion: C3 targeted complement therapy may be regarded as a valuable adjunct to non-surgical periodontal treatment for CP. However, the results are still under investigation and require further verification through clinical trials.


How to cite this article:
Agnihotri R, Gaur S. C3 targeted complement therapy for chronic periodontitis – A scoping review.J Int Soc Prevent Communit Dent 2022;12:500-505


How to cite this URL:
Agnihotri R, Gaur S. C3 targeted complement therapy for chronic periodontitis – A scoping review. J Int Soc Prevent Communit Dent [serial online] 2022 [cited 2022 Nov 30 ];12:500-505
Available from: https://www.jispcd.org/article.asp?issn=2231-0762;year=2022;volume=12;issue=5;spage=500;epage=505;aulast=Agnihotri;type=0